Liver cirrhosis: vizsgálatok itt: Kanada
11 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KanadaWithin-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT07877298 - 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Edmonton, Montreal, Terrebonne, Toronto, Vaughan
- Életkor
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - 3. fázisTaking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Bridgewater, Calgary, Montreal, Québec, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - 2. fázisNot yet taking people in KanadaA Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Where
- Edmonton
- Életkor
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07325526 - No phaseNot yet taking people in KanadaProspective AI-SC Trial
- Where
- Toronto
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- University Health Network, Toronto
See details and how to joinNCT07927153 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Calgary, London, Ottawa, Toronto, Vancouver, Vaughan, Winnipeg
- Életkor
- 18 év to 75 év
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - 2. fázisNot yet taking people in KanadaStudy to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
- Where
- Toronto
- Életkor
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- Madrigal Pharmaceuticals, Inc.
See details and how to joinNCT07335601 - No phaseNot yet taking people in KanadaPersonalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy
- Where
- Montreal
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07634237 - No phaseTaking peopleLiver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Where
- Edmonton, Toronto
- Életkor
- 18 év to 80 év
- People
- 3000 worldwide
- Run by
- European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921 - No phaseTaking peopleCirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial
- Where
- Edmonton
- Életkor
- 18 év and over
- People
- 3975
- Run by
- University of Alberta
See details and how to joinNCT04149223 - No phaseTaking peopleCanadian Network for Autoimmune Liver Disease
- Where
- Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Saskatoon, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 18 év and over
- People
- 2500
- Run by
- University Health Network, Toronto
See details and how to joinNCT03569826